Stockreport

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF SAN DIEGO, April 02, 2024 BUSINESS WIRE )--LENZ Therapeutics, Inc. (Nasdaq: LENZ or "LENZ" or the "Company"), a late clinical-stage biopharmaceutical company focused on [Read more]